Where was the Kepivance® phase 3 clinical trial conducted?
The phase 3 clinical trial was conducted in 13 different centers including2: • City of Hope National Medical Center, Duarte, CA • Fred Hutchinson Cancer Research Center, Seattle, WA • Georgetown University Cancer Center, Washington, DC • Loyola University Medical Center, Maywood, IL • Medical College of Virginia, Richmond, VA • Memorial Sloan Kettering Cancer Center, New York, NY • Northwest Marrow Transplant Center, Portland, OR • Sinai Hospital of Baltimore, Baltimore, MD • SUNY Upstate Medical University, Syracuse, NY • Texas Transplant Institute, San Antonio, TX • UCLA Division of Hematology/Oncology, Los Angeles, CA • University of Minnesota, Minneapolis, MN • University of North Carolina, Chapel Hill, NC
